BioVie Inc. - Common stock — Balance Sheet (NASDAQ:BIVI) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Total assets 6.05 M20.11 M35.1 M25.21 M21.56 M14.25 M Total liabilities 996.37 K16.44 M19.76 M9.7 M2.55 M3.98 M Total equity 5.05 M3.67 M15.34 M15.51 M19.01 M10.27 M Total liabilities & shareholders' equities 6.05 M20.11 M35.1 M25.21 M21.56 M14.25 M Total debt 012.14 M14.33 M5.7 M—— Net debt -4.51 M-6.5 M-5.13 M-18.14 M——

News

BioVie Inc. (BIVI) Discusses Bezisterim Mechanism of Action and SUNRISE-PD Phase II Trial Design Transcript

BioVie Inc. (BIVI) Discusses Clinical Updates on Bezisterim and BIV201 for Parkinson's, Alzheimer's, and Ascites Transcript

BioVie Inc. (BIVI) Discusses Bezisterim's Mechanism of Action and Its Potential in Addressing Parkinson's Disease Pathology Transcript

BioVie Inc. (BIVI) Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID Transcript

BioVie completes enrollment for Parkinson’s drug trial

What Makes BioVie (BIVI) a New Buy Stock

BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease Transcript

BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease - Slideshow (NASDAQ:BIVI) 2025-12-09

BioVie shareholders approve amendment to equity incentive plan at annual meeting

BioVie shareholders approve board nominees and equity plan at annual meeting

Akari Therapeutics appoints Kameel Farag as interim CFO

BioVie Inc. - Special Call